Medsafe (New Zealand Medicines and Medical Devices Safety Authority, Ministry of Health)
Is Bremelanotide (PT-141) legal in New Zealand?
Not approvedNo bremelanotide product is approved by Medsafe; melanocortin-type peptides are prescription-only
Not approved as a medicine here.
Medsafe's index of data sheets for consented medicines, revised 29 September 2026, lists no bremelanotide product (no Vyleesi entry). The Medsafe classification database has a group entry for melanocyte-stimulating compounds as prescription medicines, which is a classification and not an approval. Without ministerial consent it cannot lawfully be sold, supplied or advertised outside narrow prescriber exemptions. Medsafe's product search showed no bremelanotide product on 29 September 2026.
Last verified 2026-09-29 · how we verify
Bremelanotide (PT-141) elsewhere
Sources (5)
- 01Data sheets index (medicines with consent to be distributed in New Zealand)Medsafe (New Zealand Medicines and Medical Devices Safety Authority) · 2026-09-29 · accessed 2026-09-29
- 02Medicines Classification Database (Schedule 1, Medicines Regulations 1984)Medsafe (New Zealand Medicines and Medical Devices Safety Authority) · 2026-09-25 · accessed 2026-09-29
- 03Medicines Act 1981 (version as at 10 July 2026)New Zealand Parliamentary Counsel Office · 2026-07-10 · accessed 2026-09-29
- 04Use of Unapproved Medicines and Use of approved Medicines for an unapproved purposeMedsafe (New Zealand Medicines and Medical Devices Safety Authority) · 2025-12-12 · accessed 2026-09-29
- 05Product/Application Search (product and application records searched by ingredient on 29 September 2026)Medsafe (New Zealand Medicines and Medical Devices Safety Authority) · 2026-07-07 · accessed 2026-09-29